Screener
Alaunos Therapeutics TCRT Q4 2025 Annual earnings
Reported March 31, 2026
Revenue$3.0KIn line
EPS-$0.40Beat by $3.29
Revenue estimate$3.0K
EPS estimate-$3.69
Next report
Nov 17, 2026 (in 2 months)EPS estimate-$15.75
Versus estimates
Revenue
Q4 2025$3.0KIn line
Q1 2025$2.0KDiluted EPS
Q2 2026-$0.41Q1 2026-$0.59
Q4 2025-$0.40Beat by $3.29
Q3 2025-$0.55Beat by $4.35Q2 2025-$0.63Beat by $4.70Q1 2025-$0.67Beat by $5.77FAQ
- When did Alaunos Therapeutics report Q4 2025 earnings?
- Alaunos Therapeutics (TCRT) reported Q4 2025 earnings on March 31, 2026.
- What were Alaunos Therapeutics's Q4 2025 revenue and EPS?
- Alaunos Therapeutics reported revenue of $3.0K and eps of $-0.40 for Q4 2025.
- Did Alaunos Therapeutics beat estimates in Q4 2025?
- Revenue beat the consensus estimate of $3.0K by -. EPS beat the consensus estimate of $-3.69 by $3.29.
- How did Alaunos Therapeutics's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 25.0% from $4.0K a year earlier and eps grew 13.0% from $-0.46.
- Where can I find Alaunos Therapeutics's Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001193125-26-134720) directly on SEC EDGAR. The filing index links above go to sec.gov.
